ELEVESS

Anika’s first HA-based dermal filler, ELEVESS^™, is available in the EU, Canada and the U.S., through physicians trained in dermal filler injections.  ELEVESS is packaged in units of 1 mL, a volume appropriate for filling of facial lines of medium depth, particularly nasolabial folds.

ELEVESS, like other dermal fillers, is injected directly into patients’ skin; however, the formulation of our product reduces injection pain through the addition of the anesthetic lidocaine. Long-lasting, more natural effects, combined with ease of use and patient comfort are a result of the highest concentration of HA of any available dermal filler. ELEVESS is the first HA-based dermal filler approved in the U.S. to include lidocaine in its formulation, greatly increasing patient comfort during the injection procedure. Additional benefits of ELEVESS include a unique, patented HA crosslinker, an ergonomically designed syringe and unique extrusion properties that allow easy injection through a 30g needle.

ELEVESS has been enthusiastically received by physicians and patients, and Anika is currently working to expand the dermal filler product portfolio through the addition of products such as a fine line dermal filler, a volume filler and a lip product.